Single-dose Methotrexate in Obstetrics & Gynecology — Case | General Gynecology | SMLE Q#1573
SMLE Question #1573
Obstetrics & Gynecology
General Gynecology
Objective: OBJ-ETH-STERIL
Last updated: February 2026
A 27-year-old G2P0 woman is followed in an outpatient gynecology clinic for a tubal ectopic pregnancy treated medically 2 weeks ago with single-dose methotrexate. Her serum β-hCG decreased by more than 15% between day 4 and day 7 and continues to decline. She reports mild improving pelvic discomfort and minimal spotting. Abdominal examination shows no tenderness or peritoneal signs. What is the most appropriate next step in management?
Continue in practice mode
Sign in and start a focused practice session to view options, submit your answer, and read the full explanation.